Participants reporting cravings several times a week showed a slight decrease from 3.1% (12 participants) to 2.8% (11 participants) after GLP-1 use
Sleepiness is more pronounced among people who consume a lot of carbs
Glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)a dual GIP/GLP-1 receptor agonisthave transformed the management of type 2 diabetes and obesity
Semaglutide and Gut-Related Side Effects: What to Expect As effective as Semaglutide is, some individuals may experience temporary digestive side effects like nausea, bloating, or constipation
An adjuvant treatment with AR-GLP1 can reduce the glucose variability, and therefore reduce the overall risks
Injectable glutathione bypasses the digestive system, where oral glutathione undergoes significant breakdown by stomach acid and intestinal enzymes